Trials / Completed
CompletedNCT07115810
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The goal of this observational study is to compare the clinical outcomes, molecular features, and immune profiles of patients with synchronous and metachronous distant metastases in Saudi cohort with well characterized differentiated thyroid cancer. The main question it aims to answer is whether timing of metastasis is associated with distinct prognostic or biological behavior in differentiated thyroid cancer from a large Middle Eastern cohort
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No additional drugs(control Group) | No intervention |
Timeline
- Start date
- 1988-01-01
- Primary completion
- 2018-12-31
- Completion
- 2024-12-31
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Source: ClinicalTrials.gov record NCT07115810. Inclusion in this directory is not an endorsement.